SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: kbert who wrote (541)10/28/1998 10:11:00 PM
From: jhild  Respond to of 1286
 
I have read the white papers. They are all written by the company. Several of them do quote testing that they have apparently paid for, but it seemed when I read them yesterday that none of them had a list of citations supporting clinical tests published by any medical journals specifically about the efficacy of their products. I found this an important lapse. Generally, in medical publications peer review is an important validating step in publishing results.

These white papers are akin to publishing un-audited financials. And by golly they have done that too now haven't they?



To: kbert who wrote (541)10/28/1998 10:13:00 PM
From: xbrent  Read Replies (1) | Respond to of 1286
 
I complained about the Boston website a couple weeks ago. I was told that they are working on it. FGRX was the vehicle to get Boston public. But FGRX is in early development. I was told that if anyone wanted to they could visit the four FGRX business sites early in November.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News